$21.490
-0.011 (-0.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NAMS Prediction & Forecast by Similar Chart Analysis
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.28 (-0.96%). The 1-week path is $21.51 (+0.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy NewAmsterdam Pharma Company NV Stock?
NewAmsterdam Pharma is not a good buy right now due to significant financial losses and negative market sentiment. The stock is currently priced at $19.83, down 43.66% year-to-date, and has an RSI of 25.93, indicating it is oversold. The company reported a net loss of $64.1 million in Q2 2026, a substantial increase from previous losses, which raises concerns about its financial health and market competitiveness. Additionally, insider selling has increased by 113.69%, suggesting a lack of confidence from those closest to the company. The main risk is the forward P/E ratio of 119.05, indicating high valuation expectations that may not be met given the current financial performance.
NAMS stock price ended at $21.49 on Wednesday, after losing -0.05%
NewAmsterdam Pharma Company NV (NAMS) last closed at $21.49, losing -0.05%. These facts feed the 1-day and 1-week NAMS price prediction above.
Forecast Drivers
NewAmsterdam Pharma Company NV (NAMS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NAMS, ranked by similarity.
Seasonality analysis for NAMS
Historically the probability of a positive October return for NAMS is 75.41%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NAMS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $24.81 | $32.88 | $41.42 | +52.99% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +94.60% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +91.52% |
In 2026, NewAmsterdam Pharma Company NV (NAMS) is projected to range from $24.81 to $49.82.
NewAmsterdam Pharma Company NV 2026 monthly forecast
In Oct 2026, NewAmsterdam Pharma Company NV is projected to average $32.88, with a low of $24.81 and high of $41.42.
In Nov 2026, NewAmsterdam Pharma Company NV is projected to average $41.82, with a low of $33.96 and high of $49.82.
In Dec 2026, NewAmsterdam Pharma Company NV is projected to average $41.16, with a low of $33.82 and high of $42.47.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.